Loading field map
Health insurance is a system for financing health care by pooling financial risk across a group of people. In its most basic form, an insurer collects regular payments—premiums—from many individuals or households and uses those funds to pay for the medical care of the few who need it at any given time. Because illness and injury are unpredictable for any single person but statistically regular for a large group, the pool can absorb costs that would be ruinous for an individual. Health insurance is thus not itself a medical service but a financial arrangement that determines who pays for care, how much they pay, and under what conditions care is delivered.
The field of health insurance as a discipline sits at the intersection of economics, public policy, and actuarial science. It studies how these risk-pooling arrangements are designed, priced, regulated, and experienced, and it asks what happens when the assumptions behind them fail. Its central questions concern efficiency, equity, and sustainability: How can insurance protect people from financial catastrophe without encouraging them to overuse care? How can insurers avoid attracting only the sick while excluding the healthy? And how can a society ensure that insurance is available and affordable to those who need it, including the poor and the chronically ill?
The rationale for health insurance rests on two facts: health care is expensive, and the need for it is uncertain. Without insurance, a person facing a serious illness might have to exhaust savings, sell assets, or forgo treatment entirely. By paying a predictable premium, individuals trade a small certain loss for the risk of a large uncertain one. This is welfare-improving if people are risk-averse—that is, if they prefer a guaranteed moderate loss to a small chance of a devastating one.
But health insurance is not like insurance against fire or car accidents, because the insured event is not entirely outside the insured person's control. People can influence their need for care through lifestyle choices, and once insured, they face weaker incentives to avoid care because they do not bear its full cost. This creates two classic problems that organize much of the field.
The first is moral hazard. When insurance lowers the out-of-pocket price of care, people may demand more care than they would if they paid the full price. Some of this additional care is valuable—a person with a chronic condition might finally afford necessary treatment—but some may be of low value, where the cost exceeds the benefit. The empirical question of how much health insurance actually increases utilization, and whether that increase is worthwhile, has driven decades of research. The famous RAND Health Insurance Experiment of the 1970s and 1980s, which randomly assigned families to insurance plans with different levels of cost-sharing, found that people in plans with higher copayments used less care, but that their health outcomes were on average no worse, except for the poorest and sickest participants. This finding has shaped the widespread use of copayments and deductibles, though its interpretation remains debated.
The second problem is adverse selection. People know more about their own health risks than insurers do. If an insurer charges a single premium to everyone, the healthy may find it too expensive and drop out, leaving a pool that is sicker and more expensive than average. The insurer must then raise premiums, driving out more of the relatively healthy, in a spiral that can end with only the sickest insured at very high prices. In the extreme, a market can unravel entirely. This problem is not merely theoretical; it has been observed in real insurance markets, and it explains why private health insurance markets rarely function like ordinary competitive markets. Insurers respond by trying to predict risk—through medical underwriting, which charges higher premiums to those with pre-existing conditions—or by designing plans that appeal to the healthy, such as those with high deductibles and low premiums. Regulators respond with rules that limit underwriting, mandate coverage, or require everyone to purchase insurance.
A third problem, risk selection, is related but distinct. Even when insurers cannot deny coverage, they may have incentives to attract healthy enrollees and discourage sick ones, because sick enrollees cost more than their premiums. Insurers can do this by designing benefits that appeal to the young and healthy (such as gym memberships) while offering poor coverage for the services the chronically ill need (such as expensive specialty drugs). This is not fraud; it is a rational response to the incentive structure. The field studies how payment systems and regulations can be designed to reward insurers for providing good care rather than for selecting good risks.
Health insurance has features that distinguish it from property or life insurance and that make its economics distinctive. First, the "loss" is not a fixed amount but depends on decisions made after the loss occurs. A fire destroys a house of known value; an illness can be treated in many ways at many different costs. The insurer is therefore not just paying for a loss but influencing the treatment decision itself. This is why health insurers are deeply involved in managing care—through prior authorization, provider networks, and utilization review—in ways that fire insurers are not.
Second, health care is not a homogeneous good. The same procedure can be life-saving for one patient and unnecessary for another, and the patient often cannot judge its value. This creates a role for physicians as agents who recommend care, but it also means that the insurer cannot simply rely on the patient to demand only appropriate care. The field therefore studies how payment incentives affect physicians' behavior, not just patients'.
Third, health is a merit good in most societies: people believe that access to care should not depend entirely on ability to pay. This normative commitment is why health insurance is so heavily regulated and why nearly all wealthy countries have some form of universal coverage, whether through a single government payer, regulated private insurers, or a mix. The economic analysis of health insurance is therefore inseparable from questions of distributive justice, even when the analysis is conducted in the technical language of welfare economics.
The field is organized less by rival schools than by complementary methods that address different questions. Four approaches are particularly important.
Actuarial and statistical approaches focus on the technical problem of pricing risk. Actuaries estimate the probability and cost of future claims using data on demographics, medical history, and population health trends. Their methods—life tables, morbidity curves, and more recent predictive models using machine learning—determine the premiums that insurers must charge to remain solvent. This is the oldest tradition in insurance, dating to the life insurance tables of the seventeenth and eighteenth centuries, and it remains the foundation of insurance practice. Its limitation is that it takes the demand for care as given; it does not ask whether the care is worth its cost or whether the premium is fair.
Welfare economics and the theory of insurance markets provide the conceptual framework for understanding when insurance markets work and when they fail. This tradition, associated with economists such as Kenneth Arrow and Mark Pauly in the 1960s, analyzes insurance as a response to risk and asks how moral hazard and adverse selection distort the optimal contract. Arrow's famous 1963 article "Uncertainty and the Welfare Economics of Medical Care" argued that the uncertainty of illness and the special nature of medical care create market failures that justify non-market institutions, including insurance and possibly government provision. Pauly responded that moral hazard is not a market failure but a rational response to subsidies, and that the optimal insurance contract should include cost-sharing to limit overuse. This debate—whether the problems of health insurance are inherent market failures or manageable incentive problems—still frames much of the field.
Empirical health economics tests these theories with data. This approach, which became dominant in the late twentieth century, uses natural experiments, randomized trials, and large administrative datasets to measure how people and providers respond to insurance incentives. The RAND experiment is the canonical example, but the field has since developed a rich toolkit. Researchers have used the introduction of Medicare in the United States, the expansion of Medicaid, and the rollout of insurance reforms in other countries to estimate the effects of insurance on health, financial well-being, and utilization. This tradition has produced some of the field's most robust findings: that insurance reduces out-of-pocket spending and financial distress, that it increases the use of care, and that its effects on physical health are real but often modest and slow to appear.
Health policy and health services research takes a more institutional and normative approach. It asks how insurance systems should be organized to achieve goals like universal coverage, equity, and cost control, and it studies the actual operation of real insurance systems. This tradition is less concerned with formal theory than with comparative institutional analysis: how do single-payer systems, social health insurance, and regulated private markets differ in their outcomes? It draws on political science, sociology, and public health as much as on economics. Its contribution is to keep the field grounded in the practical questions that motivate it: who is uninsured, why, and what can be done?
These approaches are not rivals so much as layers. Actuarial science prices the risk; welfare economics explains why the market for that risk is problematic; empirical economics measures the magnitude of the problems; and health policy asks what to do about them. A complete understanding of health insurance requires all four.
Health insurance as a mass institution is a twentieth-century phenomenon, though its precursors are older. Mutual aid societies and friendly societies, in which workers pooled funds to cover sickness and burial costs, existed in Europe and North America in the nineteenth century. These were voluntary, community-based arrangements that provided a form of income replacement during illness rather than payment for medical care itself. The connection to modern health insurance is real but indirect; these societies did not typically pay for physicians' services, and they were organized around solidarity rather than actuarial risk.
The first modern health insurance systems emerged in Europe in the late nineteenth century. Germany's social health insurance legislation of the 1880s, introduced under Otto von Bismarck, required workers in certain industries to contribute to sickness funds that paid for medical care. This was a political response to the rise of socialism and the demands of the labor movement, not a purely economic innovation. It established the model of social health insurance: mandatory enrollment, contributions shared between workers and employers, and governance by quasi-public funds. This model spread across continental Europe and later to Japan, Korea, and other countries. It remains the dominant form of coverage in many wealthy nations.
A different model developed in the United Kingdom, where the Beveridge Report of 1942 led to the creation of the National Health Service in 1948. This is a national health service rather than insurance in the strict sense: care is financed from general taxation and provided by publicly employed staff, and there is no insurance pool or premium. The NHS is often grouped with health insurance systems because it serves the same function of protecting people from the cost of care, but its economics are different. There is no risk pool because there is no insurance; the government simply budgets for health care like any other public service.
The third major model is private health insurance, which developed most fully in the United States. Private insurance grew in the United States during the 1930s and 1940s, partly as a response to the Great Depression and partly because wage controls during World War II encouraged employers to offer health benefits as a way to attract workers. The result was a system of employer-sponsored insurance that now covers most working-age Americans. The United States is the only wealthy country that relies primarily on private, employment-based insurance, and it also has public programs—Medicare for the elderly and Medicaid for the poor—that were added in 1965. The American system is the subject of enormous study because it is the most market-oriented of the wealthy countries' systems and because it leaves a significant share of the population uninsured.
These three models—social insurance, national health service, and private insurance—are ideal types, and real systems mix them. The Netherlands and Switzerland require individuals to purchase private insurance but regulate it heavily and subsidize the poor. Germany's system includes private insurers alongside the statutory funds. Even the United States, with its private system, spends more public money on health care than many countries with universal coverage, through tax subsidies for employer insurance and the public programs.
The contemporary study of health insurance is shaped by several persistent tensions. The first is the trade-off between risk protection and cost control. Insurance that covers everything is expensive and encourages overuse; insurance that requires high cost-sharing protects less against financial risk. The field has not resolved this trade-off; it has only learned to measure it more precisely. The move toward high-deductible plans in the United States, and toward reference pricing and managed care in other countries, reflects a judgment that the moral hazard problem is more serious than the risk-protection problem. Whether that judgment is correct remains an open empirical question.
The second tension is between solidarity and actuarial fairness. Social insurance systems charge the same premium to the sick and the healthy, the old and the young, and they often subsidize the poor. Private insurance markets, left to themselves, charge each person according to their risk. The field studies how much solidarity a society can afford and how much risk-rating it will tolerate. Most countries have chosen a strong form of solidarity: community rating (charging everyone the same premium) is common, and risk adjustment—in which funds are transferred from insurers with healthy enrollees to those with sick ones—is used to make competition compatible with solidarity.
The third tension is between public and private provision. The debate is not simply about whether government should provide insurance; it is about what role private insurers can play in a system that guarantees universal coverage. Some countries, like Canada, exclude private insurance for publicly covered services. Others, like Germany and the Netherlands, use private insurers as administrators within a tightly regulated framework. The empirical evidence does not show that one model is clearly superior on health outcomes; all wealthy countries achieve similar life expectancy and mortality rates. The differences are in cost, equity, and administrative complexity.
A fourth issue, increasingly important, is the relationship between insurance and the delivery of care. Insurers do not merely pay bills; they shape how care is organized. The rise of managed care in the United States, in which insurers contract with specific providers and require prior authorization for certain services, was an attempt to control costs by influencing clinical decisions. The backlash against managed care in the late 1990s showed the political limits of this approach. More recently, payment reforms such as bundled payments and accountable care organizations have tried to align the incentives of insurers and providers by paying for outcomes rather than services. Whether these reforms will succeed in controlling costs without harming quality is one of the field's most active research areas.
Finally, the field is grappling with the challenge of the uninsured and the underinsured. Even in wealthy countries, gaps in coverage persist. In the United States, the uninsured rate has fluctuated with policy changes but remains substantial. In countries with universal coverage, underinsurance—in which people have coverage but face high out-of-pocket costs or limited benefits—has become a growing concern as premiums and copayments have risen. The study of health insurance is therefore not only about the design of ideal systems but about the persistent failures of real ones.
Health insurance is a field in which technical analysis and normative commitment are inseparable. The actuarial tables and econometric estimates matter because they tell us who bears the cost of illness and who is left unprotected. The field's enduring questions—how much risk to pool, how much cost to share, how much solidarity to require—are economic questions with moral consequences. Its methods have become more sophisticated over time, but its central subject remains the same: the human need for care, the unpredictability of illness, and the social arrangements that connect the two.